Key terms

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SYK news

May 02 10:06pm ET Stifel Nicolaus Keeps Their Buy Rating on Stryker (SYK) May 02 7:48am ET Stryker price target raised to $376 from $372 at Barclays May 02 3:51am ET Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Sarepta Therapeutics (SRPT) May 01 11:08am ET Stryker (SYK) Gets a Buy from Piper Sandler May 01 9:06am ET Bank of America Securities Reaffirms Their Buy Rating on Stryker (SYK) May 01 8:19am ET Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Charles River Labs (CRL) and Neurocrine (NBIX) May 01 8:19am ET Stryker price target raised to $405 from $348 at Roth MKM May 01 7:15am ET Stryker price target raised to $369 from $366 at BTIG May 01 6:57am ET Stryker price target raised to $378 from $367 at Baird May 01 6:39am ET RBC Capital Sticks to Its Buy Rating for Stryker (SYK) May 01 6:31am ET Analysts’ Top Healthcare Picks: Stryker (SYK), Foghorn Therapeutics (FHTX) May 01 6:13am ET Stryker price target raised to $381 from $364 at Wells Fargo May 01 6:10am ET Stryker’s Strong Q1 Performance and Positive Growth Outlook Affirm Buy Rating May 01 5:59am ET Stryker’s Solid Performance Tempered by Growth Concerns: A Cautious Hold Recommendation May 01 12:25am ET JMP Securities Sticks to Their Hold Rating for Stryker (SYK) Apr 30 4:12pm ET Stryker sees FY24 adjusted EPS $11.85-$12.05, consensus $11.85 Apr 30 4:11pm ET Stryker reports Q1 adjusted EPS $2.50, consensus $2.35 Apr 30 1:37pm ET Notable companies reporting after market close Apr 22 7:56am ET Stryker added to ‘Tactical Outperform’ list at Evercore ISI Apr 22 5:05am ET Stryker’s Resilience Amidst Competitive Pressures Reinforces Buy Rating Apr 17 10:40am ET Analysts Offer Insights on Healthcare Companies: Agilent (A), GlaxoSmithKline (GSK) and Stryker (SYK) Apr 16 7:03am ET Orthofix names Andres Cedron chief legal officer Apr 15 8:10am ET Stryker price target raised to $386 from $360 at RBC Capital Apr 15 7:36am ET Stryker price target raised to $366 from $353 at BTIG Apr 11 7:23am ET Stryker price target raised to $400 from $365 at TD Cowen Apr 06 5:08am ET Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Novartis AG (Six Swiss: CH:NOVN) and AstraZeneca (GB:AZN) Apr 06 5:05am ET Analysts Offer Insights on Healthcare Companies: Shop Apotheke Europe NV (GB:0RJT), Stryker (SYK) and Novartis AG (Six Swiss: CH:NOVN) Apr 03 5:53am ET Stryker price target raised to $406 from $362 at Citi Feb 23 10:11am ET Stryker price target raised to $380 from $335 at Argus Feb 21 7:25am ET BTIG medical technology analyst to hold analyst/industry conference call Feb 21 4:55am ET BTIG medical technology analyst to hold analyst/industry conference call

No recent press releases are available for SYK

SYK Financials

1-year income & revenue

Key terms

SYK Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SYK Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms